NCT04205864View on ClinicalTrials.gov

Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

July 2, 2020

Conditions
LymphoceleLymphocele After Surgical ProcedureEndometrium Cancer
Interventions
DRUG

Thrombi-Gel

Thrombin gel Matrix applied on pelvic lymphadenectomy areas after lympadenectomy

PROCEDURE

Conventional Pelvic lymphadenectomy

Conventional Pelvic lymphadenectomy

Trial Locations (1)

41380

Kocaeli University, Kocaeli

All Listed Sponsors
lead

Kocaeli University

OTHER

NCT04205864 - Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer. | Biotech Hunter | Biotech Hunter